Home › Glioblastoma › Distretto di Columbia › Washington
Studi clinici su Glioblastoma a Washington, DC
15 studi su Glioblastoma cercano partecipanti presso sedi a Washington e dintorni (entro circa 30 miglia). Apri uno studio per vedere chi può partecipare e come contattare il team.
Testo ufficiale dello studio (inglese)
Stai reclutando per uno studio? Mettilo in evidenza in cima alla pagina — $99 per 30 giorni →
Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
In reclutamentoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Study of Silevertinib With Temozolomide for the Treatment of Newly Diagnosed GBM With Unmethylated MGMT and EGFRvIII
In reclutamentoFase 2
- Johns Hopkins Sibley Memorial Hospital, Washington D.C.
Targeted Pediatric High-Grade Glioma Therapy
In reclutamentoStudio osservazionale
- Children's National Medical Center, Washington D.C.
Study of Olutasidenib and Temozolomide in HGG
In reclutamentoFase 2
- Children's National Medical Center, Washington D.C.
Hypofractionation Trial of Re-irradiation in Good Prognosis Recurrent Glioblastoma
In reclutamentoFase 1
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
PLX038 in Primary Central Nervous System Tumors Containing MYC or MYCN Amplifications
In reclutamentoFase 1/2
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Collection of Blood and Urine Samples in Patients Receiving Radiation Therapy for Glioblastoma Multiforme
In reclutamentoStudio osservazionale
- National Institutes of Health Clinical Center, Bethesda · a 7 mi di distanza
Lorlatinib for Newly-Diagnosed High-Grade Glioma With ROS or ALK Fusion
In reclutamentoFase 1 inizialeVolontari sani benvenuti
- Children's National Medical Center, Washington D.C.
A Study of RNA-lipid Particle (RNA-LP) Vaccines for Newly Diagnosed Pediatric High-Grade Gliomas (pHGG) and Adult Glioblastoma (GBM)
In reclutamentoFase 1
- Children's National Hospital, Washington D.C.
ONC206 for Treatment of Newly Diagnosed, Recurrent Diffuse Midline Gliomas, and Other Recurrent Malignant CNS Tumors
In reclutamentoFase 1
- Children's National Hospital, Washington D.C.
Study of Ribociclib and Everolimus in HGG and DIPG or Ribociclib and Temozolomide in DHG, H3G34-mutant
In reclutamentoFase 2
- Children's National Medical Center, Washington D.C.
Safety and Tolerability of TNG456 Alone and in Combination With Abemaciclib in Patients With Solid Tumors With MTAP Loss
In reclutamentoFase 1/2
- Sibley Memorial Hospital, Washington D.C.
Phase I Study of Oral ONC206 in Recurrent and Rare Primary Central Nervous System Neoplasms
In reclutamentoFase 1
- National Institutes of Health, Bethesda · a 7 mi di distanza
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
In reclutamentoStudio osservazionale
- Massive Bio SYNERGY-AI site, Silver Spring · a 7 mi di distanza
- Massive Bio SYNERGY-AI site, Bethesda · a 7 mi di distanza
Study of Liposomal Curcumin in Combination With RT and TMZ in Patients With Newly Diagnosed High-Grade Gliomas
In reclutamentoFase 1/2
- Sibley Memorial Hospital, Washington D.C.
Studi su Glioblastoma in altre città
- New York City, NY30 studi
- Boston, MA28 studi
- Houston, TX26 studi
- Los Angeles, CA24 studi
- Durham, NC20 studi
- San Francisco, CA17 studi
- Chicago, IL15 studi
- Columbus, OH14 studi
- Miami, FL14 studi
- Rochester, MN13 studi
- Jacksonville, FL13 studi
- Aurora, CO12 studi
Altri studi a Washington
- Cancro (tutti i tipi)58 studi
- Cancro del polmone non a piccole cellule55 studi
- Cancro al seno46 studi
- Cancro metastatico43 studi
- Cancro ai polmoni41 studi
- Cancro alla prostata38 studi
- Obesità33 studi
- Cancro colorettale29 studi
- Malattie cardiovascolari28 studi
- Cancro della vescica26 studi
- Leucemia mieloide acuta24 studi
- Cancro ovarico23 studi
Fonte: ClinicalTrials.gov, dati recuperati il 6 ott 2026. Ogni studio stabilisce i propri criteri di idoneità; è il team di ricerca a decidere chi può partecipare.